Rhabdomyolysis: An Evaluation of 475 Hospitalized Patients
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
Rhabdomyolysis is a common and potentially lethal clinical syndrome that results from acute muscle fiber necrosis with leakage of muscle constituents into blood. Myoglobinuria is the most significant consequence, leading to acute renal failure (ARF) in 15%-33% of patients with rhabdomyolysis. Rhabdomyolysis occurs from inherited diseases, toxins, muscle compression or overexertion, or inflammatory processes, among other disorders. In some cases, no cause is found. We describe 475 patients from the Johns Hopkins Hospital inpatient records between January 1993 and December 2001 for the following discharge diagnosis codes: myoglobinuria, rhabdomyolysis, myopathy, toxic myopathy, malignant hyperthermia, neuroleptic malignant syndrome, and polymyositis. Of 1362 patients, 475 patients with an acute neuromuscular illness with serum creatine kinase (CK) more than 5 times the upper limit of normal (>975 IU/L) were included. Patients with recent myocardial infarction or stroke were excluded. The etiology was assigned by chart review. For all, the highest values of serum CK, serum creatinine and urine myoglobin, hemoglobin, and red blood cells were recorded. Forty-one patients had muscle biopsy within at least 2 months from the onset of rhabdomyolysis.Of the 475 patients, 151 were female and 324 were male (median age, 47 yr; range, 4-95 yr). Exogenous toxins were the most common cause of rhabdomyolysis, with illicit drugs, alcohol, and prescribed drugs responsible for 46%. Among the medical drugs, antipsychotics, statins, zidovudine, colchicine, selective serotonin reuptake inhibitors, and lithium were the most frequently involved. In 60% of all cases, multiple factors were present. In 11% of all cases, rhabdomyolysis was recurrent. Underlying myopathy or muscle metabolic defects were responsible for 10% of cases, in which there was a high percentage of recurrence, only 1 etiologic factor, and a low incidence of ARF. In 7%, no cause was found. ARF was present in 218 (46%) patients, and 16 died (3.4%). A linear correlation was found between CK and creatinine and between multiple factors and ARF, but there was no correlation between ARF and death or between multiple factors and death. Urine myoglobin detected by dipstick/ultrafiltration was positive in only 19%. Toxins are the most frequent cause of rhabdomyolysis, but in most cases more than 1 etiologic factor was present. Patients using illicit drugs or on prescribed polytherapy are at risk for rhabdomyolysis. The absence of urine myoglobin, by qualitative assay, does not exclude rhabdomyolysis. With appropriate care, death is rare.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Spectrum of Rhabdomyolysis
GABOW, P. A., KAEHNY, W. D., & KELLEHER, S. P. (1982) · Medicine · doi:10.1097/00005792-198205000-00002 · Cited by 1,078
Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs
Graham, D. J. (2004) · JAMA · doi:10.1001/jama.292.21.2585 · Cited by 875
Factors Predictive of Acute Renal Failure in Rhabdomyolysis
Ward, M. M. (1988) · Archives of Internal Medicine · doi:10.1001/archinte.148.7.1553 · Cited by 464
Warren, J. D., Blumbergs, P. C., & Thompson, P. D. (2002) · Muscle & Nerve · doi:10.1002/mus.10053 · Cited by 431
Nontraumatic Rhabdomyolysis and Acute Renal Failure
Grossman, R. A., Hamilton, R. W., Morse, B. M., Penn, A. S., & Goldberg, M. (1974) · New England Journal of Medicine · doi:10.1056/nejm197410172911601 · Cited by 377
Non-traumatic rhabdomyolysis and acute renal failure.
Chang, C.-H., Fang, J., & Huang, C. (1996) · PubMed · Cited by 367
Neurological complications of sepsis: critical illness polyneuropathy and myopathy
Hund, E. (2001) · Journal of Neurology · doi:10.1007/s004150170043 · Cited by 171
Marked Elevations of Serum Creatine Kinase Activity Associated with Antipsychotic Drug Treatment
Meltzer, H. (1996) · Neuropsychopharmacology · doi:10.1016/0893-133x(95)00276-j · Cited by 165
Necrotizing myopathy in critically‐ill patients
Helliwell, T. R., Coakley, J. H., Wagenmakers, A. J. M., Griffiths, R. D., Campbell, I. T., Green, C. J., McClelland, P., & Bone, J. M. (1991) · The Journal of Pathology · doi:10.1002/path.1711640406 · Cited by 151
Metabolic causes of myoglobinuria
Tonin, P., Lewis, P., Servidei, S., & DiMauro, S. (1990) · Annals of Neurology · doi:10.1002/ana.410270214 · Cited by 148
A Syndrome of Acute Severe Muscle Necrosis in Intensive Care Unit Patients
Ramsay, D. A., Zochodne, D. W., Robertson, D. M., Nag, S., & Ludwin, S. K. (1993) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199307000-00006 · Cited by 129
DiMauro, S., & Lamperti, C. (2001) · Muscle & Nerve · doi:10.1002/mus.1103 · Cited by 124
Biochemical investigation of suspected rhabdomyolysis
Beetham, R. (2000) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/0004563001899870 · Cited by 106
Recurrent myoglobinuria due to a nonsense mutation in the COX I gene of mitochondrial DNA
Karadimas, C. L., Greenstein, P. E., Sue, C. M., Joseph, J. T., Tanji, K., Haller, R. G., Taivassalo, T., Davidson, M. M., Shanske, S., Bonilla, E., et al. (2000) · Neurology · doi:10.1212/wnl.55.5.644 · Cited by 105
Iatrogenic and toxic myopathies
Sieb, J. P., & Gillessen, T. (2002) · Muscle & Nerve · doi:10.1002/mus.10244 · Cited by 92
Quadriplegic areflexic ICU illness: Selective thick filament loss and normal nerve histology
Sander, H. W., Golden, M., & Danon, M. J. (2002) · Muscle & Nerve · doi:10.1002/mus.10233 · Cited by 78
Metabolic causes of recurrent rhabdomyolysis
Löfberg, M., Jänkälä, H., Paetau, A. E., et al. (1998) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1998.tb07307.x · Cited by 65
Polymyosites induites ou associées aux traitements hypolipémiants ?
Fauchais, A. L., Ba, J. I., Maurage, P., Kyndt, X., Bataille, D., HACHULLA, E., Parent, D., Queyrel, V., Lambert, M., Pasturel, U. M., et al. (2003) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2003.10.013 · Cited by 58
Recurrent Childhood Myoglobinuria
Tein, I., DiMauro, S., & Vivo, D. C. D. (1990) · Advances in Pediatrics · doi:10.1016/s0065-3101(24)00240-8 · Cited by 46
Argov, Z. (2000) · Current Opinion in Neurology · doi:10.1097/00019052-200010000-00006 · Cited by 46
Csako, G., McGriff, N. J., Rotman-Pikielny, P., Sarlis, N. J., & Pucino, F. (2001) · Annals of Pharmacotherapy · doi:10.1345/aph.1a031 · Cited by 40
Rastegar, D. A., Claiborne, C. V., Fleisher, A., et al. (2001) · Clinical Infectious Diseases · doi:10.1086/318508 · Cited by 28
Penzak, S. R., & Chuck, S. K. (2002) · Expert Opinion on Drug Safety · doi:10.1517/14740338.1.1.5 · Cited by 28
Rose, M. R., Kissel, J. T., Bickley, L. S., & Griggs, R. C. (1996) · Neurology · doi:10.1212/wnl.47.1.119 · Cited by 19
DISORDERS OF LIPID METABOLISM IN SKELETAL MUSCLE
Cwik, V. A. (2000) · Neurologic Clinics · doi:10.1016/s0733-8619(05)70183-3 · Cited by 19
Ultrafiltration discrepancies in recovery of myoglobin from urine
Loun, B., Copeland, K. R., & Sedor, F. A. (1996) · Clinical Chemistry · doi:10.1093/clinchem/42.6.965 · Cited by 15
Review of exertional rhabdomyolysis and a case in a rhesus monkey (Macaca mulatta)
Reuter, J. D., Dysko, R. C., & Chrisp, C. E. (1998) · Journal of Medical Primatology · doi:10.1111/j.1600-0684.1998.tb00080.x · Cited by 6
Cited by
Rhabdomyolysis and Acute Kidney Injury
Bosch, X., Poch, E., & Grau, J. M. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0801327 · Cited by 1,488
The safety of statins in clinical practice
Armitage, J. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60716-8 · Cited by 833
Rhabdomyolysis: Review of the literature
Zutt, R., van der Kooi, A. J., Linthorst, G. E., Wanders, R. J. A., & de Visser, M. (2014) · Neuromuscular Disorders · doi:10.1016/j.nmd.2014.05.005 · Cited by 737
A framework for diagnosing and classifying intensive care unit-acquired weakness
Stevens, R. D., Marshall, S. A., Cornblath, D. R., Hoke, A., Needham, D. M., de Jonghe, B., Ali, N. A., & Sharshar, T. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181b6ef67 · Cited by 698
Self-citationStatin Adverse Effects: A Review of the Literature and Evidence for a Mitochondrial Mechanism
Golomb, B. A., & Evans, M. A. (2008) · American Journal of Cardiovascular Drugs · doi:10.2165/0129784-200808060-00004 · Cited by 677
Metadata
- Authors
- Melli, G., Chaudhry, V., & Cornblath, D. R.
- Venue
- Medicine
- Published
- 2005-11
- Volume
- 84
- Issue
- 6
- Pages
- 377-385
- ISSN
- 0025-7974 (ISSN-L)
- OpenAlex
- W1967701621
- Cited by
- 629
- References
- 27
- FWCI
- 13.82
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.